Mechanisms of Developmental Fidelity
发展忠诚度机制
基本信息
- 批准号:8954933
- 负责人:
- 金额:$ 18.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-05 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AnimalsApoptosisAutomobile DrivingCaenorhabditis elegansCell DeathCell ProliferationCell divisionCellsCessation of lifeComplexCongenital AbnormalityDecision MakingDefectDevelopmentDevelopmental ProcessDisastersEmbryoEnsureEnvironmentEventExploratory/Developmental GrantFaceFrequenciesGeneticGenetic VariationGenomeGonadal structureGrowthHandednessHumanHuman DevelopmentInbreedingIndividualLawsLeadLeftLengthLongevityMalignant NeoplasmsModelingMolecularMolecular GeneticsNematodaNeurodegenerative DisordersNeuronsNoiseOperating SystemOrganOutcomeOutputParentsPregnancyProbabilityProcessQuality ControlQuantitative Trait LociRecombinantsSensoryStructureSystemTailVariantbaseegggenome sequencinggermline stem cellshigh riskinsightmalepreventpublic health relevancerestraintsuccesstraitzygote
项目摘要
DESCRIPTION (provided by applicant): Developing embryos face vast numbers of parallel and sequential decisions each that is confronted with fluctuating environments and molecular "noise," and is thus fraught with a certain rate of error. While quality control systems that corret decision-making errors must be pervasive and are critical for human development, almost nothing is known about them. The hypothesis driving the proposed studies is that there exist quality control systems operating during development that ensure high-fidelity outcomes and that such systems may function across disparate developmental processes. We will avail of the highly reproducible development of C. elegans to investigate the mechanisms that regulate developmental fidelity. We found that C. elegans males show frequent "errors" in the activation of programmed cell death (PCD) during formation of the tail ray sensory structures and in the left-right (L/R) orientation of the major organs and that the propensity for these errors differs widely between different wild isolates (isotypes). Isotypes with high error rates in these two processes ("low-fidelity" strains) also show high variance in other processes, including germline stem cell proliferation and L1 larval length. In contrast, a strain with low error rates ("high-fidelity") in the former traits also shows low variance in the latter. We propose to unveil the molecular genetic basis for stochastic PCD and errors in L/R handedness and to investigate whether the fidelity of different developmental processes might be influenced by common mechanisms, through two aims. In Aim 1, we will investigate whether variation in fidelity is fully independent or significantly co-varies across several developmental processes by analyzing errors in disparate developmental processes across 97 isotypes and recombinant inbred lines (RILs) derived from "high-" and "low-fidelity" isotypes. We will evaluate whether fidelity has an impact on other functions including growth and longevity. In Aim 2, we will identify the molecular genetic basis for variation in developmental errors/fidelity in PCD and L/R organ handedness and other events. While the high-risk/high-gain aspect of the proposed studies make them appropriate for the R21 mechanism, important results relevant to stochasticity of PCD and dysregulation of L/R organ asymmetry will be obtained regardless of the generality of fidelity-controlling mechanisms. The proposed studies promise to yield new information regarding regulatory mechanisms underlying birth defects and dysregulation of cell proliferation, including in cancer. In addition, uncovering mechanisms that lead to inappropriate, stochastic cell death may provide important insights into sporadic cell death in neurodegenerative diseases.
描述(由申请人提供):发育中的胚胎面临着大量的平行和顺序的决定,每个决定都面临着波动的环境和分子“噪音”,因此充满了一定的错误率。虽然纠正决策错误的质量控制系统必须普遍存在,对人类发展至关重要,但人们对它们几乎一无所知。驱动拟议的研究的假设是,存在质量控制系统,在开发过程中,确保高保真的结果,这样的系统可能会在不同的发展过程中发挥作用。我们将利用C. elegans研究调节发育保真度的机制。我们发现C.雄性线虫在尾鳍感觉结构形成过程中程序性细胞死亡(PCD)的激活和主要器官的左右(L/R)方向上显示出频繁的“错误”,并且这些错误的倾向在不同的野生分离株(同种型)之间差异很大。在这两个过程中具有高错误率的同种型(“低保真度”菌株)在其他过程中也显示出高变异,包括生殖系干细胞增殖和L1幼虫长度。相比之下,在前一个性状中具有低错误率(“高保真度”)的菌株在后一个性状中也显示出低方差。我们建议揭示随机PCD和错误的L/R手性的分子遗传基础,并调查是否不同的发展过程的保真度可能会受到共同的机制,通过两个目标。在目的1中,我们将调查保真度的变化是否是完全独立的或显着的共变跨越几个发展过程中的错误分析不同的发展过程中的97个同种型和重组自交系(RILs)来自“高”和“低保真度”同种型。我们将评估忠诚度是否对其他功能(包括生长和寿命)产生影响。在目标2中,我们将确定PCD和L/R器官利手和其他事件中发育错误/保真度变化的分子遗传基础。虽然高风险/高收益方面的建议的研究,使他们适合的R21机制,重要的结果相关的随机性的PCD和失调的L/R器官不对称性将获得无论生育控制机制的一般性。拟议中的研究有望产生关于出生缺陷和细胞增殖失调(包括癌症)背后的调控机制的新信息。此外,揭示机制,导致不适当的,随机的细胞死亡可能会提供重要的见解零星细胞死亡的神经退行性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel H. Rothman其他文献
Joel H. Rothman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel H. Rothman', 18)}}的其他基金
A model for elimination of defective mitochondrial genomes
消除有缺陷的线粒体基因组的模型
- 批准号:
10043796 - 财政年份:2020
- 资助金额:
$ 18.07万 - 项目类别:
MARC at the University of California Santa Barbara
加州大学圣塔芭芭拉分校 MARC
- 批准号:
10625331 - 财政年份:2020
- 资助金额:
$ 18.07万 - 项目类别:
A model for elimination of defective mitochondrial genomes
消除有缺陷的线粒体基因组的模型
- 批准号:
10266765 - 财政年份:2020
- 资助金额:
$ 18.07万 - 项目类别:
Developmental reprogramming and transorganogenesis
发育重编程和跨器官发生
- 批准号:
10588050 - 财政年份:2015
- 资助金额:
$ 18.07万 - 项目类别:
UC Santa Barbara MARC Program: Bridges to Biomedical Research Careers
加州大学圣巴巴拉分校 MARC 项目:通向生物医学研究职业的桥梁
- 批准号:
8856392 - 财政年份:2015
- 资助金额:
$ 18.07万 - 项目类别:
Developmental reprogramming and transorganogenesis
发育重编程和跨器官发生
- 批准号:
8888152 - 财政年份:2015
- 资助金额:
$ 18.07万 - 项目类别:
Plasticity in an embryonic gene regulatory network
胚胎基因调控网络的可塑性
- 批准号:
9020247 - 财政年份:2015
- 资助金额:
$ 18.07万 - 项目类别:
Plasticity in an embryonic gene regulatory network
胚胎基因调控网络的可塑性
- 批准号:
10299492 - 财政年份:2015
- 资助金额:
$ 18.07万 - 项目类别:
UC Santa Barbara MARC Program: Bridges to Biomedical Research Careers
加州大学圣巴巴拉分校 MARC 项目:通向生物医学研究职业的桥梁
- 批准号:
9482449 - 财政年份:2015
- 资助金额:
$ 18.07万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 18.07万 - 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 18.07万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 18.07万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 18.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 18.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 18.07万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 18.07万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 18.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 18.07万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 18.07万 - 项目类别:
Discovery Grants Program - Individual